Further investment in Embark
Further investment in Embark

Perth, Nov 12, 2018 AEST (ABN Newswire) - MMJ Group Holdings Limited (googlechartASX:MMJ) (googlechart2P9:FRA) (googlechartMMJJF:OTCMKTS) ("MMJ") is pleased to announce that it has invested CAD$2.5 million of equity into privately-held Embark Health Inc ("Embark"). This increases MMJ's total investment in Embark to CAD$2.65 million for a basic shareholding of circa 10%*.

MMJ's CEO Jason Conroy commented that "We are delighted by the opportunity to make a significant follow-on investment in Embark to support Bruce Dawson-Scully and his experienced management team in developing the quintessential cannabis extraction facility to service Canadian and global medical and recreational markets."

For further information on Embark, please visit:
http://embarkhealthinc.com


About MMJ Group Holdings Ltd

Phytotech Medical ASX:PYL

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/

https://plus.google.com/112611716213432048650/posts https://www.youtube.com/channel/UCkDxKKC_fe2TdZfeVSpPVhw abnnewswire.com 


Contact

Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819
E: info@mmjgh.com.au



ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 12) (Last 30 Days: 51) (Since Published: 6643)